Wednesday, March 28, 2018

Haemonetics Announces Regulatory Clearances of NexSys PCS™ Enhanced Software with YES™ Technology

HAE logo April 2016.Embedded Software Adds Key Capability to NexSys PCS Platform BRAINTREE, Massachusetts, March 28, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for enhancement of its NexSys PCS™ embedded...




from PR Newswire: //https://ift.tt/2IaNt7i
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)